title: Association between the microarray-based CYP2C19 genotyping assay and the platelet function test in cardiovascular patients receiving clopidogrel.
authors.affiliation: Departments of Laboratory Medicine, Dong-A University College of Medicine, Busan, Korea.
authors.forename: J-L
authors.initials: JL
authors.lastname: Choi
authors.forename: B-R
authors.initials: BR
authors.lastname: Kim
authors.forename: J-E
authors.initials: JE
authors.lastname: Kim
authors.forename: K-S
authors.initials: KS
authors.lastname: Woo
authors.forename: K-H
authors.initials: KH
authors.lastname: Kim
authors.forename: J-M
authors.initials: JM
authors.lastname: Kim
authors.forename: M-H
authors.initials: MH
authors.lastname: Kim
authors.forename: J-Y
authors.initials: JY
authors.lastname: Han
mesh_terms: D054058:Acute Coronary Syndrome / Q000208:ethnology / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D000244:Adenosine Diphosphate / Q000378:metabolism; D000483:Alleles; D044466:Asian People; D001241:Aspirin / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19 / Q000235:genetics* / Q000378:metabolism; D015870:Gene Expression; D005838:Genotype; D006801:Humans; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism; D046228:Microarray Analysis; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011110:Polymorphism, Genetic; D058925:Receptors, Purinergic P2Y12 / Q000235:genetics / Q000378:metabolism; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D007527:Isoenzymes; C548576:P2RY12 protein, human; D010975:Platelet Aggregation Inhibitors; D058925:Receptors, Purinergic P2Y12; D000244:Adenosine Diphosphate; D000077144:Clopidogrel; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine; D001241:Aspirin